Search
Sugammadex
go.drugbank.com/drugs/DB06206ApprovedInvestigationalSugammadex (brand name Bridion) is marketed by Merck Sharp and Dohme, and was approved by the United States FDA on December 15, 2015.
Products: Sugammadex Aguettant 50 mg/ml Injektionslösung in einer Fertigspritze, BRIDION 500 MG/5 ML IV ENJEKSIYONLUK COZELTI ICEREN 10 FLAKONAmpicillin
go.drugbank.com/drugs/DB00415ApprovedInvestigationalVet approvedAmpicillin is a semi-synthetic derivative of penicillin that functions as an orally active broad-spectrum antibiotic.
Mixtures: AZOSILIN 500 MG/50 MG TABLET, 30 ADET, AZOSILIN 500 MG/50 MG TABLET, 12 ADETCategories: Penicillin GMeperidine
go.drugbank.com/drugs/DB00454ApprovedInvestigationalA narcotic analgesic that can be used for the relief of most types of moderate to severe pain, including postoperative pain and the pain of labor. Prolonged use may lead to dependence of the morphine type; withdrawal symptoms appear more...
Categories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP1A2 InducersProducts: Demerol 50 mg/ml (multiple Dose With Metacresol As Preservative), ALDOLAN 100 MG/2 ML AMPUL, 5 ADETNiacin
go.drugbank.com/drugs/DB00627ApprovedInvestigationalNutraceuticalNiacin is a B vitamin used to treat vitamin deficiencies as well as hyperlipidemia, dyslipidemia, hypertriglyceridemia, and to reduce the risk of myocardial infarctions.
Mixtures: Niacin 500 Mg and Inositol, Luna Vitamin and Mineral Bar for WomenCategories: Cytochrome P-450 CYP2D6 Inhibitors, Cytochrome P-450 CYP2E1 InhibitorsCeftibuten
go.drugbank.com/drugs/DB01415ApprovedInvestigationalCeftibuten is a third-generation cephalosporin antibiotic that is orally-administered. It is typically used to treat acute bacterial exacerbations of chronic bronchitis (ABECB), acute bacterial otitis media, pharyngitis, and tonsilitis.
Mixtures: WINCEF PLUS 180/62.5 MG/5 ML ORAL SUSPANSIYON HAZIRLAMAK ICIN KURU TOZ, 100 ML, WINCEF PLUS 90/62.5 MG 5 ML ORAL SUSPANSIYON HAZIRLAMAK ICIN KURU TOZ, 100 MLSynonyms: (+)-(6R,7R)-7-((Z)-2-(2-amino-4-thiazolyl)-4-carboxycrotonamido)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acidVildagliptin
go.drugbank.com/drugs/DB04876ApprovedInvestigationalIt is marketed as Galvus.[L32803] Vildagliptin is also available as Eucreas, a fixed-dose formulation with metformin for adults in who do not adequately glycemic control from monotherapy. … [L32803] In clinical trials, vildagliptin has a relatively low risk of hypoglycemia.
Mixtures: GALVUS MET (50 MG/1000 MG), XILIARX MET (50 MG/1000 MG)Products: DIYATIX 50 MG TABLET, 180 ADET, GLIPTA 50 MG TABLET, 180 ADETSitagliptin
go.drugbank.com/drugs/DB01261ApprovedInvestigationalSitagliptin was granted FDA approval on October 16, 2006[L6061].
Mixtures: JANUMET 50 MG/1000 MG FILM KAPLI TABLET, 56 ADET, VELMETIA 50/1000 MG FILM KAPLI TABLET, 56 ADETCategories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A SubstratesInsulin human
go.drugbank.com/drugs/DB00030ApprovedInvestigationalMarketed as the brand name product Humulin R or Novolin R, human insulin begins to exert its effects within 30 minutes of subcutaneous administration, while peak levels occur 3-4 hours after administration … Human Insulin is a 51 residue peptide hormone produced by recombinant DNA technology by inserting the human insulin gene into Escherichia coli bacteria or Saccharomyces cerevisiae.
Mixtures: GENSULIN M 40 (40/60) 100 IU/ML, GENSULIN M 40 (40/60) 100 IU/MLCategories: Cytochrome P-450 CYP1A2 Inducers, Cytochrome P-450 Enzyme InducersTetracycline
go.drugbank.com/drugs/DB00759ApprovedInvestigationalVet approvedWithdrawnThe FDA withdrew its approval for the use of all liquid oral drug products formulated for pediatric use containing tetracycline in a concentration greater than 25 mg/ml. … It also binds to some extent to the bacterial 50S ribosomal subunit and may alter the cytoplasmic membrane causing intracellular components to leak from bacterial cells.
Mixtures: Pylera 140 mg/125 mg/125 mg Hartkapseln, Pylera 140 mg/125 mg/125 mg HartkapselnCategories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A InhibitorsUbidecarenone
go.drugbank.com/drugs/DB09270ApprovedInvestigationalNutraceuticalFrom its name (Q10), the Q refers to the constitutive quinone group, and 10 is related to the number of isoprenyl subunits in its tail. … [L1062] Ubidecarenone is sold as a dietary supplement and is not FDA approved as a drug - it is not meant to treat, cure or prevent any disease.
Mixtures: Medi-10, PreQue 10Synonyms: Co-enzyme Q 10, Coenzyme Q 10